The Neuro is patient care, Open Science research and training.

Peter McPherson

Neuroscience lab turns attention to COVID-19

16 Jun 2020

Researchers use their cell biology expertise to understand how the virus enters cells

Major ALS Research Funding Announced

Published: 23Nov2016

MNI scientists will study stem cells, genetic mutations to develop new treatments...

ALS – Fostering awareness of a devastating disease

Published: 2Jun2017

ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the...

June is ALS Month

Published: 7Jun2018

A look at the latest ALS research and clinical care at The Neuro...

Using patients’ own cells to accelerate research into neurological disease

Published: 31Mar2015

$1 M gift from Mr. J. Sebastian van Berkom launches translational research into neurological disease ...

ALS Awareness Month – June

Published: 2Jun2015

As a major Canadian centre for amyotrophic lateral sclerosis (ALS) research and treatment, the Montreal Neurological Institute and Hospital - The Neuro, invites the public and the media to learn...

ALS Awareness Month – June 2016

Published: 13Jun2016

The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about...

MNI researchers receive funding to study ARSACS

Published: 24Nov2016

Two researchers at the Montreal Neurological Institute and Hospital (MNI) of McGill University have received funding to study a devastating neurodegenerative disease that first appears in toddlers...

Pages

The Neuro logo McGill logoMcGill University Health Centre logoKillam logo

The Neuro is a McGill research and teaching institute; delivering high quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

Back to top